NCT03852823 2021-04-30
Study of Recombinant Human Anti-PD-1 Monoclonal Antibody in Patients With Advanced Tumours
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Phase 1 Unknown
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Shenzhen BinDeBio Ltd.
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine